Nicolas earned his PharmD from the University of Bordeaux and Dipl. Ing from the Institute of Biotechnology of Bordeaux. He has occupied various positions in the biopharmaceutical industry. While working at Merck Serono, Switzerland, he helped define the Process control Strategy for a commercial molecule. Nicolas now works as an USP scientist in the late stage development department at Sanofi, managing the team in charge of the upstream process characterization of a new biologic molecule.